These effects, along with a preceding report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the concept of targeting ACKR3 as a singular solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Problems.A exploration analyze released in Anesthes